drugset / Trial / NCT00938730
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to investigate the optimal daily dose and dose regimen of YM150 in subjects with non-valvular atrial fibrillation (NVAF), primarily based on safety and tolerability data.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Warfarin | Small molecule | — | Oral |
| Subject | darexaban | Small molecule | — | Oral |